Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathias Freund

Showing results (61-70 of 76) with videos related to

Pageof 8
Sort By:
BMC Cancer|October 19, 2010
The multikinase inhibitor Sorafenib displays significant antiproliferative effects and induces apoptosis via caspase 3, 7 and PARP in B- and T-lymphoblastic cellsCatrin Schult, Meike Dahlhaus, Sabine Ruck, et al.
Molecular and Clinical Oncology|July 24, 2014
Conditioning with treosulfan and fludarabine for patients with refractory or relapsed non-Hodgkin lymphomaMichael Schmitt, Rudolf Trenschel, Herbert G Sayer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 15, 2010
Validation of the human activity profile questionnaire in patients after allogeneic hematopoietic stem cell transplantationPhilipp Yorck Herzberg, Pia Heussner, Friederike H A Mumm, et al.
Leukemia & Lymphoma|May 6, 2014
Granulocyte-colony stimulating factor response is superior to neutropenia duration in predicting the risk of infection after high-dose chemotherapy for myeloma and lymphomaChristian Straka, Hans Salwender, Brigitte Schnabel, et al.
Blood|July 9, 2004
Myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission prolongs progression-free survival in follicular lymphoma: results of a prospective, randomized trial of the German Low-Grade Lymphoma Study GroupGeorg Lenz, Martin Dreyling, Eva Schiegnitz, et al.
Bone Marrow Transplantation|May 30, 2003
Myeloablative intensified conditioning regimen with in vivo T-cell depletion (ATG) followed by allografting in patients with advanced multiple myeloma. A phase I/II study of the German Study-group Multiple Myeloma (DSMM)Nicolaus Kröger, Hermann Einsele, Daniel Wolff, et al.
Journal of Adolescent and Young Adult Oncology|December 17, 2016
Building a National Framework for Adolescent and Young Adult Hematology and Oncology and Transition from Pediatric to Adult Care: Report of the Inaugural Meeting of the "AjET" Working Group of the German Society for Pediatric Oncology and HematologyGabriele Escherich, Stefan Bielack, Stephan Maier, et al.
Blood|March 24, 2012
Adult patients with acute lymphoblastic leukemia and molecular failure display a poor prognosis and are candidates for stem cell transplantation and targeted therapiesNicola Gökbuget, Michael Kneba, Thorsten Raff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 26, 2010
Allogeneic hematopoietic stem-cell transplantation in patients with hematologic malignancies after dose-escalated treosulfan/fludarabine conditioningJochen Casper, Daniel Wolff, Wolfgang Knauf, et al.
Blood|April 12, 2012
Outcome of relapsed adult lymphoblastic leukemia depends on response to salvage chemotherapy, prognostic factors, and performance of stem cell transplantationNicola Gökbuget, Daniel Stanze, Joachim Beck, et al.
Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
BMC Cancer|October 19, 2010
The multikinase inhibitor Sorafenib displays significant antiproliferative effects and induces apoptosis via caspase 3, 7 and PARP in B- and T-lymphoblastic cellsCatrin Schult, Meike Dahlhaus, Sabine Ruck, et al.
Molecular and Clinical Oncology|July 24, 2014
Conditioning with treosulfan and fludarabine for patients with refractory or relapsed non-Hodgkin lymphomaMichael Schmitt, Rudolf Trenschel, Herbert G Sayer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 15, 2010
Validation of the human activity profile questionnaire in patients after allogeneic hematopoietic stem cell transplantationPhilipp Yorck Herzberg, Pia Heussner, Friederike H A Mumm, et al.
Leukemia & Lymphoma|May 6, 2014
Granulocyte-colony stimulating factor response is superior to neutropenia duration in predicting the risk of infection after high-dose chemotherapy for myeloma and lymphomaChristian Straka, Hans Salwender, Brigitte Schnabel, et al.
Blood|July 9, 2004
Myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission prolongs progression-free survival in follicular lymphoma: results of a prospective, randomized trial of the German Low-Grade Lymphoma Study GroupGeorg Lenz, Martin Dreyling, Eva Schiegnitz, et al.
Bone Marrow Transplantation|May 30, 2003
Myeloablative intensified conditioning regimen with in vivo T-cell depletion (ATG) followed by allografting in patients with advanced multiple myeloma. A phase I/II study of the German Study-group Multiple Myeloma (DSMM)Nicolaus Kröger, Hermann Einsele, Daniel Wolff, et al.
Journal of Adolescent and Young Adult Oncology|December 17, 2016
Building a National Framework for Adolescent and Young Adult Hematology and Oncology and Transition from Pediatric to Adult Care: Report of the Inaugural Meeting of the "AjET" Working Group of the German Society for Pediatric Oncology and HematologyGabriele Escherich, Stefan Bielack, Stephan Maier, et al.
Blood|March 24, 2012
Adult patients with acute lymphoblastic leukemia and molecular failure display a poor prognosis and are candidates for stem cell transplantation and targeted therapiesNicola Gökbuget, Michael Kneba, Thorsten Raff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 26, 2010
Allogeneic hematopoietic stem-cell transplantation in patients with hematologic malignancies after dose-escalated treosulfan/fludarabine conditioningJochen Casper, Daniel Wolff, Wolfgang Knauf, et al.
Blood|April 12, 2012
Outcome of relapsed adult lymphoblastic leukemia depends on response to salvage chemotherapy, prognostic factors, and performance of stem cell transplantationNicola Gökbuget, Daniel Stanze, Joachim Beck, et al.
Pageof 8